0

IBD 2007 - Achievements in Research and Clinical Practice

Falk Symposium 159

Erschienen am 15.02.2008, 1. Auflage 2008
160,49 €
(inkl. MwSt.)

Lieferbar innerhalb 1 - 2 Wochen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9781402069864
Sprache: Englisch
Umfang: xvi, 297 S.
Einband: gebundenes Buch

Beschreibung

InhaltsangabeList of principal contributors List of chairpersons Preface SECTION I: EPIDEMIOLOGY, RISK FACTORS AND GENETICS.- 1 Epidemiology and genetics of inflammatory bowel disease in Turkey.- 2 Inflammatory bowel disease in Greece: 25 years' epidemiological and clinical studies.- 3 Inflammatory bowel disease in southern Europe.- 4 Comparison to North and Central Europe.- SECTION II: BACTERIAL AND VIRAL INFECTIONS MIMICKING INFLAMMATORY BOWEL DISEASE.- 5 Ileocolonic tuberculosis: a diagnostic challenge.- 6 Bacterial and viral infections mimicking inflammatory bowel diseases.- 7 Inflammatory bowel disease coexistent with viral hepatitis and HIV SECTION III: DIAGNOSTIC STANDARDS AND DEVELOPMENTS.- 8 Endoscopic and histological grading in inflammatory bowel disease 9 Conventional imaging SECTION IV: CASES AND CONTROVERSIES.- 10 State-of-the-Art Lecture: What is the role of surgery for.- 11 State-of-the-Art Lecture: The changing face of inflammatory bowel disease over recent decades.- SECTION V: LABORATORY MARKERS AND OTHER TOOLS.- 12 Antibodies: useful tools or pathophysiology markers?.- 13 How to diagnose Behc¸et's and intestinal Behc¸et's disease?.- 14 Stool tests: are they useful?.- SECTION VI: FEATURES OF DRUGS USED IN INFLAMMATORY BOWEL DISEASE.- 15 Features of drugs used in inflammatory bowel disease: 5-aminosalicylic acid (mesalazine).- 16Immunosuppressive drugs in inflammatory bowel disease: azathioprine.- 17 Antibiotics and probiotics.- 18 Features of drugs used in inflammatory bowel disease.- SECTION VII: TREATMENT ALGORITHMS: 'THE STANDARD PATIENT'.- 19 Mild-to-moderate left-sided ulcerative colitis and proctitis.- 20 Treatment of mild-to-moderate episodes of extensive ulcerative colitis.- 21 Mild to moderately active ileocaecal Crohn's disease.- 22 Therapy of mild to moderate colonic Crohn's disease.- 23 State-of-the-Art Lecture: Future therapies in inflammatory bowel diseases.- SECTION VIII: CASES AND CONTROVERSIES.- 24 Management of fistulizing Crohn's disease: the conservative approach.- 25 Fistulizing Crohn's disease: the aggressive approach.- 26 Refractory ulcerative colitis: the conservative approach.- 27 Refractory ulcerative colitis: the aggressive approach.- 28 The surgical approach for refractory ulcerative colitis.- Index